Identifying optimal candidates for post-TIPS patients with HCC undergoing TACE: a multicenter observational study

Wenzhe Fan1, Bowen Zhu1, Shufan Yue2

  • 1Department of Interventional Oncology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Road, Guangzhou, 510080, People's Republic of China.

European Radiology
|December 23, 2022
PubMed
Summary

A new VACEA score accurately predicts survival for hepatocellular carcinoma (HCC) patients beyond Milan criteria after transjugular intrahepatic portosystemic shunt (TIPS) and transarterial chemoembolization (TACE). This model stratifies patients into risk groups, aiding treatment decisions.

Related Concept Videos